The effect of CP‐99994 on the responses to provocative motion in the cat
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
The NK 1 receptor antagonist CP‐99994 has been shown to prevent vomiting elicited by both peripherally and centrally acting emetogens in ferrets and dogs. These results have now been extended to another stimulus, provocative motion, and another species, the cat. CP‐99994 displaced [3 H]‐substance P from cat cortex with IC 50 of 0.52±0.08 n m. Following s.c. administration, peak plasma drug levels were achieved at 30 min. The plasma drug half life was 1.4 h. Subcutaneous administration of CP‐99994 inhibited motion‐induced vomiting in the cat with an ED 50 of 144 μg kg−1 but did not change the epiphenomena associated with provocative motion in the cat over the dose range of 30 to 300 μg kg−1. The antiemetic effect of CP‐99994 can be attributed to antagonism of the NK 1 receptor because its enantiomer, CP‐100,263, which is 900 fold weaker as an NK 1 antagonist, had no effects on any response to provocative motion. The inhibitory effect of CP‐99994 on motion‐induced retching and vomiting is consistent with a central site of antiemetic action, potentially at the level of the motor nuclei responsible for these behaviours. An investigation into whether the failure of CP‐99994 to alter the epiphenomena will also predict a lack of anti‐nausea effects in man will provide critical information on the neural organization of the emetic reflex. British Journal of Pharmacology (1997) 120, 116–120; doi:10.1038/sj.bjp.0700888
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Crampton, G. H. (1990) · Medical Entomology and Zoology · Cited by 273
Pharmacology of CP-99,994; a nonpeptide antagonist of the tachykinin neurokinin-1 receptor.
McLean, S., Ganong, A., Seymour, P. A., Snider, R. M., Desai, M. C., Rosen, T., Bryce, D. K., Longo, K. P., Reynolds, L. S., & Robinson, G. (1993) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)39332-8 · Cited by 221
Self-citationThe anti‐emetic effects of CP‐99,994 in the ferret and the dog: role of the NK1 receptor
Watson, J. W., Gonsalves, S. F., Fossa, A. A., McLean, S., Seeger, T., Obach, S., & Andrews, P. L. R. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb16324.x · Cited by 210
Self-citationRaymond, J., Nieoullon, A., Dem�mes, D., & Sans, A. (1984) · Experimental Brain Research · doi:10.1007/bf00237993 · Cited by 209
FUNCTIONAL LOCALIZATION OF CENTRAL COORDINATING MECHANISM FOR EMESIS IN CAT
Borison, H. L., & Wang, S. C. (1949) · Journal of Neurophysiology · doi:10.1152/jn.1949.12.5.305 · Cited by 162
Anti-emetic profile of a non-peptide neurokinin NK1 receptor antagonist, CP-99,994, in ferrets
Bountra, C., Bunce, K. T., Dale, T. J., Gardner, C., JORDAN, C. C., Twissell, D. J., & Ward, P. R. B. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90673-6 · Cited by 156
Emetic reflex arc revealed by expression of the immediate-early gene c- fos in the cat
Miller, A., & Ruggiero, D. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-02-00871.1994 · Cited by 129
The tachykinin NK1 receptor antagonist CP-99,994 attenuates cisplatin induced emesis in the ferret
Tattersall, F. D., Rycroft, W., Hargreaves, R. J., & Hill, R. G. (1993) · European Journal of Pharmacology · doi:10.1016/0014-2999(93)90649-3 · Cited by 112
Serotonin and the Scientific Basis of Anti-Emetic Therapy,
Reynolds, D. J., Andrews, P. L., & Davis, C. J. (1995) · doi:10.21236/ada304800 · Cited by 105
‘Vomiting center’ reanalyzed: an electrical stimulation study
Miller, A. D., & Wilson, V. J. (1983) · Brain Research · doi:10.1016/0006-8993(83)90805-3 · Cited by 101
Research works printed but not linked: 9
- Andrews P.L.R., 1994, 5‐Ht‐3 Receptor Antagonists, 255
- Bhandari P., 1992, Mechanisms and Control of Emesis, 239
- Gallagher J.P., 1987, Space Life Science Symposium: Three Decades of Life Science Research in Space, 206
- Grelot L., 1993, Vestibular and visceral inputs to nucleus solitarius and adjacent structures in the cat brainstem, Soc. Neurosci. Abstr., 19, 1492
- Leslie R.A., 1992, Mechanism and Control of Emesis
- Lucot J.B., 1992, Mechanisms and Control of Emesis
- Morrow G.R., 1995, Serotonin and the Scientific Basis of Anti‐emetic Therapy, 253
- Rycroft W., 1995, Serotonin and the Scientific Basis of Anti‐emetic Therapy, 267
- Tattersall F.D., 1995, Serotonin and the Scientific Basis of Anti‐emetic Therapy, 253
Cited by
The tachykinin NK1 receptor. Part II: Distribution and pathophysiological roles
Quartara, L., & Maggi, C. A. (1998) · Neuropeptides · doi:10.1016/s0143-4179(98)90015-4 · Cited by 292
Physiological basis and pharmacology of motion sickness: an update
Yates, B. J., Miller, A. D., & Lucot, J. B. (1998) · Brain Research Bulletin · doi:10.1016/s0361-9230(98)00092-6 · Cited by 230
Self-citationPostoperative nausea and vomiting in paediatric patients
Rose, J. B., & Watcha, M. F. (1999) · British Journal of Anaesthesia · doi:10.1093/bja/83.1.104 · Cited by 227
Motion Sickness: Current Knowledge and Recent Advance.
Zhang, L., Wang, J., Qi, R., Pan, L., Li, M., & Cai, Y. (2016) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12468 · Cited by 216
Potential of Substance P Antagonists as Antiemetics
Diemunsch, P., & Gr??lot, L. (2000) · Drugs · doi:10.2165/00003495-200060030-00002 · Cited by 188
Roles of Substance P and NK1 Receptor in the Brainstem in the Development of Emesis
Saito, R., Takano, Y., & Kamiya, H. (2003) · Journal of Pharmacological Sciences · doi:10.1254/jphs.91.87 · Cited by 159
Tattersall, F. D., Rycroft, W., Cumberbatch, M. J., Mason, G. S., Tye, S. J., Williamson, D. J., Hale, J. J., Mills, S. G., Finke, P. E., MacCoss, M., et al. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(99)00172-0 · Cited by 142
Hickman, M. A., Cox, S. R., Mahabir, S. P., Miskell, C., Lin, J. C.-Y., BUNGER, A., & McCall, R. B. (2008) · Journal of Veterinary Pharmacology and Therapeutics · doi:10.1111/j.1365-2885.2008.00952.x · Cited by 134
Darmani, N. A., & Ray, A. P. (2009) · Chemical Reviews · doi:10.1021/cr900117p · Cited by 110
The Role of Tachykinins and the Tachykinin NK1 Receptor in Nausea and Emesis
Andrews, P. L. R., & Rudd, J. A. (2004) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-18891-6_12 · Cited by 91
Andrews, P. L. R., Okada, F., Woods, A. J., Hagiwara, H., Kakaimoto, S., Toyoda, M., & Matsuki, N. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703428 · Cited by 79
Tachykinin receptor antagonists in clinical trials
Quartara, L., Altamura, M., Evangelista, S., & Maggi, C. A. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780903379530 · Cited by 71
Inhibition of emesis by tachykinin NK1 receptor antagonists in Suncus murinus (house musk shrew)
Rudd, J. A., Ngan, M. P., & Wai, M. K. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00920-0 · Cited by 62
Potential role of the NK 1 receptor antagonists in chemotherapy-induced nausea and vomiting
Hesketh, P. J. (2001) · Supportive Care in Cancer · doi:10.1007/s005200000199 · Cited by 58
Conder, G. A., SEDLACEK, H. S., Boucher, J. F., & Clemence, R. G. (2008) · Journal of Veterinary Pharmacology and Therapeutics · doi:10.1111/j.1365-2885.2008.00990.x · Cited by 57
Efficacy of maropitant for preventing vomiting associated with motion sickness in dogs
Benchaoui, H. A., Siedek, E. M., de la Puente-Redondo, V. A., Tilt, N., ROWAN, T. G., & Clemence, R. G. (2007) · Veterinary Record · doi:10.1136/vr.161.13.444 · Cited by 53
Reid, K., Palmer, J. L., Wright, R. J., Clemes, S. A., Troakes, C., Somal, H. S., House, F., & Stott, J. R. R. (2000) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2000.00221.x · Cited by 41
Mechanisms, causes, investigation and management of vomiting disorders in cats: a literature review
Batchelor, D. J., Devauchelle, P., Elliott, J., Elwood, C. M., Freiche, V., Gualtieri, M., Hall, E. J., den Hertog, E., Neiger, R., Peeters, D., et al. (2013) · Journal of Feline Medicine and Surgery · doi:10.1177/1098612x12473466 · Cited by 37
The effect of serotonin and serotonin receptor antagonists on motion sickness in Suncus murinus
Javid, F. A., & Naylor, R. J. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(02)00955-3 · Cited by 34
Smith, J. E., Paton, J. F. R., & Andrews, P. L. R. (2002) · Experimental Physiology · doi:10.1113/eph8702424 · Cited by 33
Fukuda, H., Nakamura, E., Koga, T., Furukawa, N., & Shiroshita, Y. (1999) · Brain Research · doi:10.1016/s0006-8993(98)01324-9 · Cited by 32
The neurokinin‐1 antagonist activity of maropitant, an antiemetic drug for dogs, in a gerbil model
de la Puente-Redondo, V. A., Tingley, F. D., SCHNEIDER, R. P., & Hickman, M. A. (2007) · Journal of Veterinary Pharmacology and Therapeutics · doi:10.1111/j.1365-2885.2007.00847.x · Cited by 29
Fukuda, H., Koga, T., Furukawa, N., Nakamura, E., & Shiroshita, Y. (1999) · Neuroscience Research · doi:10.1016/s0168-0102(98)00106-0 · Cited by 28
Rudd, J. A., Ngan, M. P., Lu, Z., Higgins, G. A., Giuliano, C., Lovati, E., & Pietra, C. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00263 · Cited by 28
Pharmacology of Motion Sickness
Lucot, J. B. (1998) · Journal of Vestibular Research · doi:10.3233/ves-1998-8109 · Cited by 26
Self-citationChan, S. W., Lu, Z., Lin, G., Yew, D. T. W., Yeung, C. K., & Rudd, J. A. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.03.016 · Cited by 25
Lau, A. H. Y., Rudd, J. A., & Yew, D. T. W. (2005) · Behavioural Pharmacology · doi:10.1097/00008877-200512000-00002 · Cited by 21
Horn, C. C. (2016) · Springer eBooks · doi:10.1007/978-3-319-34076-0_2 · Cited by 21
Antiemetics for Cancer Chemotherapy-Induced Nausea and Vomiting: A Review of Agents in Development
Rizk, A. N., & Hesketh, P. J. (1999) · Drugs in R&D · doi:10.2165/00126839-199902040-00001 · Cited by 19
Tanihata, S., Oda, S., Kakuta, S., & Uchiyama, T. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01311-6 · Cited by 18
Effects of N-methyl-d-aspartate antagonists on different measures of motion sickness in cats
Lucot, J. B. (1998) · Brain Research Bulletin · doi:10.1016/s0361-9230(98)00093-8 · Cited by 16
Self-citationAndrews, P. L. R., Golding, J. F., & Sanger, G. J. (2023) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.15852 · Cited by 15
Tools for the Approach of Fear, Anxiety, and Stress in the Domestic Feline: An Update
Barrios, F., Ruiz, P., & Damián, J. P. (2025) · Veterinary Medicine International · doi:10.1155/vmi/9109397 · Cited by 13
Wang, J.-Q., Qi, R.-R., Zhou, W., Tang, Y.-F., Pan, L.-L., & Cai, Y.-L. (2015) · PLOS ONE · doi:10.1371/journal.pone.0124203 · Cited by 11
Horii, A., Nakagawa, A., Uno, A., Kitahara, T., Imai, T., Nishiike, S., Takeda, N., & Inohara, H. (2011) · Brain Research · doi:10.1016/j.brainres.2011.11.047 · Cited by 9
Li, B. K., & Sunku, B. K. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4377-0774-8.10009-0 · Cited by 9
Effects of naloxone on motion sickness in cats alone and with broad spectrum antiemetics
Lucot, J. B. (2016) · Autonomic Neuroscience · doi:10.1016/j.autneu.2016.08.018 · Cited by 8
Self-citationChapter 6. Recent Advances in Neurokinin Receptor Antagonists
Mills, S. G. (1997) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(08)61464-5 · Cited by 7
Le, K. (2017) · Journal of Exotic Pet Medicine · doi:10.1053/j.jepm.2017.08.007 · Cited by 6
Tachykinin NK1 Receptor Antagonists
Patacchini, R., & Maggi, C. A. (2004) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-18891-6_6 · Cited by 6
Postoperative Nausea and Vomiting
Andrews, P. L. R. (1999) · Springer eBooks · doi:10.1007/978-3-642-60200-9_31 · Cited by 6
Risk of Therapeutic Failure due to Ineffectiveness of Medication
Woring, V. E. (2011) · NASA STI Repository (National Aeronautics and Space Administration) · Cited by 4
Substance P in nausea and vomiting
Andrews, P. L. R., Rudd, J. A., & Sanger, G. J. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-22194-1.00032-x · Cited by 2
Nausea and Vomiting: Underlying Mechanisms and Upcoming Treatments.
Miller, A. D., & Ph, D. (1998) · Nihon Kikan Shokudoka Gakkai Kaiho · doi:10.2468/jbes.49.57 · Cited by 2
Li, Z., Qi, J., Lu, Z., Ngan, M. P., Liu, J. Y. H., Yang, L., Khalid, A., Liu, L., Deng, Y., Huang, X., et al. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.178435 · Cited by 1
nasa (2018)
Mokha, J. S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-67293-1.00008-6
Karrento, K., & Li, B. U. K. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-11760-2.00008-2
Wotring, V. E. (2012) · SpringerBriefs in space development · doi:10.1007/978-1-4614-3396-5_7
(2010) · NASA STI Repository (National Aeronautics and Space Administration)
Metadata
- Authors
- Lucot, J. B., Obach, R. S., McLean, S., & Watson, J. W.
- Affiliations
- Wright State University (US)
- Pfizer (United States) (US)
- Corresponding author
- Lucot, J B
- ORCID
- Obach, R S
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 1997-01
- Volume
- 120
- Issue
- 1
- Pages
- 116-120
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- PMC
- PMC1564356
- OpenAlex
- W2017744461
- Cited by
- 48
- References
- 28
- Citations by year
- 2025: 3 · 2024: 1 · 2023: 1 · 2021: 1 · 2018: 1 · 2017: 1 · 2016: 3 · 2015: 2 · 2014: 1 · 2013: 1 · 2012: 1
- FWCI
- 6.13
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- British Journal of Pharmacology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Nausea and vomiting management
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Neurology › Vestibular and auditory disorders
- Keywords
- NK1 receptor antagonists, substance P, retching, antiemetic effect, emetic reflex, epiphenomena, cats, plasma pharmacokinetics
- MeSH terms
- Animals, Antiemetics, Binding, Competitive, Cats, Half-Life, Injections, Subcutaneous, Motion Sickness, Piperidines, Substance P, Vomiting, Receptors, Neurokinin-1, Area Under Curve, Neurokinin-1 Receptor Antagonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.